|Phone||44 1491 417 000|
Invesco Perpetual is a holding company. Through its subsidiaries, the company is engaged in the management and dealing of authorized unit trusts; management of individual savings accounts and personal equity plans; management of investment portfolios; provision of financial consulting services; property development, and investment holding.
|Glide Pharma||2/13||Private Equity||£14M||1|
|Lamellar Biomedical||1/13||Series A||£3.3M||4|
|Cell Medica||7/12||Venture Round||£17M||3|
|Oxford Immunotec||6/12||Venture Round||$28M||8|
|Oxford Nanopore Technologies||4/11||Series D||£25M||3|
|Oxford Nanopore Technologies||4/10||Series C||$28M||4|